The AHA Guidelines and Scientifi c Statements Handbook
Prosthetic valve (late, > 1 y)
6 IIibC Same regimens as listed
above for native valve
endocarditis with the addition
of rifampin.
Suspected Bartonella, culture negative
Ceftriaxone sodium
plus
gentamicin sulfate
with/without
doxycycline
2 g/24 h IV/IM in 1 dose 6 IIaB Patients with Bartonella
endocarditis should be
treated in consultation with
an infectious diseases
specialist.
3 mg/kg per 24 h IV/IM in 3 equally divided
doses
2
200 mg/24 h IV/PO in 2 equally divided
doses
6
Documented Bartonella, culture positive
Doxycycline
plus
gentamicin sulfate
200 mg/24 h IV or PO in 2 equally divided
doses
6 IIaB If gentamicin cannot be
given, then replace it with
rifampin, 600 mg/24 h PO/IV
3 mg/kg per 24 h IV/IM in 3 equally divided in 2 equally divided doses.
doses
Pediatric dose: Ceftriaxone 100 mg/kg per
24 h IV/IM once daily; gentamicin 3 mg/kg
per 24 h IV/IM in 3 equally divided doses;
doxycycline 2–4 mg/kg per 24 h IV/PO in 2
equally divided doses; rifampin 20 mg/kg per
24 h PO/IV in 2 equally divided doses
2
- Dosages recommended are for patients with normal renal function.
** Pediatric dose should not exceed that of a normal adult.
† See text and Table 19.4 for appropriate dosing of gentamicin.
‡ See Table 19.4 for appropriate dosing of vancomycin.
IM indicates intramuscular, and PO, oral.
Table 19.14 Continued
Regimen Dosage and route
Duration
(weeks)
Strength of
recommendation Comments
including the lungs, coronary arteries, spleen, bowel,
and extremities. Up to 65% of embolic events
involve the central nervous system, and >90% of
central nervous system emboli lodge in the distribu-
tion of the middle cerebral artery. The highest inci-
dence of embolic complications is seen with aortic
and mitral valve infections and in IE caused by S.
aureus, Candida, HACEK, and Abiotrophia organ-
isms. Emboli can occur before diagnosis, during
therapy, or after therapy is completed, although
most emboli occur within the fi rst 2 to 4 weeks of
antimicrobial therapy.
Periannular extension of infection
Extension of IE beyond the valve annulus predicts
a higher mortality rate, more frequent develop-
ment of CHF, and more frequent cardiac surgery.